Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Thromboembolism 3Venous Thrombosis 2Colorectal Neoplasms 2Venous Thromboembolism 1Vascular Diseases 1Urogenital Neoplasms 1Pulmonary Embolism 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Myeloproliferative Disorders 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lymphoma 1Lymphatic Diseases 1Lung Neoplasms 1Liver Neoplasms 1Leukemia 1Intestinal Neoplasms 1Hemostatic Disorders 1Hemorrhage 1Digestive System Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Enoxaparin 2Endoscopic Mucosal Resection 2Tranexamic Acid 1Tinzaparin 1Standard of Care 1Radiotherapy 1Proton Pump Inhibitors 1Pancreaticoduodenectomy 1Palliative Care 1Neuromuscular Blockade 1Lansoprazole 1Esomeprazole 1Data Collection 1Dalteparin 1Bevacizumab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemorrhage × Tinzaparin × Gastrointestinal × Clear all
NCT04731558 2025-02-14

PREPOSTEROUS

Helsinki University Central Hospital

Phase 4 Recruiting
1,012 enrolled
Gastrointestinal

Hemorrhage, Liver Neoplasms, Pulmonary Embolism, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡